Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in hairy cell leukaemia

Hairy cell leukaemia (HCL) is a rare chronic B lymphoproliferative disorder which can lead to severe pancytopenia and several immunologic abnormalities. The pathogenetic role of tumour necrosis factor (TNF)‐α in HCL prompted us to study the potential contribution of functionally important genetic polymorphisms of the TNF gene cluster in a large group of patients with HCL. The TNF‐α (−308  bp) promoter/enhancer point mutation and two polymorphisms located within the first intron of the lymphotoxin (LT)‐α gene showed neither significant allelic deviation for the patient group nor, after analysis of clinical characteristics such as blood counts, stable or progressive disease or response to therapy.

[1]  M. Schmid,et al.  Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia , 1997, British journal of haematology.

[2]  S. Dower,et al.  Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. , 1995, Blood.

[3]  M. Schmid,et al.  Evidence for a paracrine pathway of B‐cell stimulation in hairy cell leukaemia , 1995, British journal of haematology.

[4]  J. Falkenburg,et al.  Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. , 1994, Blood.

[5]  A. Cope,et al.  Lymphotoxin acts as an autocrine growth factor for Epstein‐Barr virus‐transformed B cells and differentiated Burkitt lymphoma cell lines , 1994, European journal of immunology.

[6]  S. Wallenstein,et al.  Increased incidence of HLA antigen B35 in patients with chronic lymphocytic leukemia. , 1994, Leukemia research.

[7]  G. Gahrton,et al.  Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. , 1994, Blood.

[8]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[9]  B. Telek,et al.  Histocompatibility antigens in hairy cell leukaemia. , 1989, Tissue antigens.

[10]  M. Turner,et al.  TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES , 1988, The Lancet.

[11]  John Calvin Reed,et al.  bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. , 1993, Blood.

[12]  G. Gahrton,et al.  Cytogenetics in CLL and related disorders. , 1993, Bailliere's clinical haematology.